Audentes Therapeutics
Audentes is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases.. Learn more
Launch date
Employees
Market cap
€72.6m
Enterprise valuation
(€90m) (Public information from Sep 2024)
Share price
$4.27 BOLD
San Francisco California (HQ)
Authorizing premium user...